CD4 and neoplasm: The vaccine therapeutic efficacy was associated with tumor-specific killing activity, high frequency of IFN-γ secreting CD4+ T and CD8+ T cells, increased intratumoral number of CD4+ T and CD8+ T cells, and a decrease in the number of CD4+FoxP3+ Treg cells [12], [13], [35].